Home/Filings/4/0001213900-20-042291
4//SEC Filing

Straube Richard 4

Accession 0001213900-20-042291

CIK 0000812796other

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 5:05 PM ET

Size

5.6 KB

Accession

0001213900-20-042291

Insider Transaction Report

Form 4
Period: 2020-12-10
Straube Richard
Sr VP & Chief Medical Officer
Transactions
  • Award

    Option (Right to Buy)

    2020-12-10+40,00040,000 total
    Exercise: $2.34From: 2020-12-10Exp: 2030-12-09Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]The stock option vested immediately as to 10,000 shares and vests as to the remainder at a rate of 2,500 of the shares on each three (3) month anniversary of December 10,2020.

Documents

1 file

Issuer

SOLIGENIX, INC.

CIK 0000812796

Entity typeother

Related Parties

1
  • filerCIK 0001595197

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:05 PM ET
Size
5.6 KB